{"id":453,"date":"2025-12-02T12:57:31","date_gmt":"2025-12-02T12:57:31","guid":{"rendered":"https:\/\/solfed.fr\/?p=453"},"modified":"2025-12-02T15:26:35","modified_gmt":"2025-12-02T15:26:35","slug":"lipoproteinea-un-marqueur-cardiovasculaire-longtemps-neglige-aujourdhui-indispensable","status":"publish","type":"post","link":"https:\/\/solfed.fr\/?p=453","title":{"rendered":"Lipoprot\u00e9ine(a) : un marqueur cardiovasculaire longtemps n\u00e9glig\u00e9, aujourd\u2019hui indispensable"},"content":{"rendered":"\n<p>La lipoprot\u00e9ine(a), souvent not\u00e9e Lp(a), est en train de devenir l\u2019un des marqueurs les plus discut\u00e9s en pr\u00e9vention cardiovasculaire. Ce sujet, trop longtemps laiss\u00e9 de c\u00f4t\u00e9, revient aujourd\u2019hui au premier plan gr\u00e2ce \u00e0 l\u2019accumulation de donn\u00e9es montrant son r\u00f4le direct dans le d\u00e9veloppement des maladies du c\u0153ur et des art\u00e8res.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Lp(a), un facteur de risque \u00e0 part<\/strong><\/h2>\n\n\n\n<p>La Lp(a) ressemble au LDL-cholest\u00e9rol, mais elle poss\u00e8de une prot\u00e9ine suppl\u00e9mentaire appel\u00e9e apo(a). Cette particularit\u00e9 la rend plus agressive pour la paroi des art\u00e8res et favorise aussi la formation de caillots. Sa concentration dans le sang d\u00e9pend presque exclusivement de facteurs g\u00e9n\u00e9tiques, ce qui explique pourquoi elle varie \u00e9norm\u00e9ment d\u2019une personne \u00e0 l\u2019autre. Certaines personnes ont un taux extr\u00eamement bas, d\u2019autres d\u00e9passent 1 g\/L sans le savoir.<\/p>\n\n\n\n<p>En France, plusieurs millions de personnes auraient une Lp(a) suffisamment \u00e9lev\u00e9e pour augmenter leur risque cardiovasculaire, sans aucun sympt\u00f4me particulier.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Un r\u00f4le d\u00e9sormais bien \u00e9tabli dans les maladies cardiovasculaires<\/strong><\/h2>\n\n\n\n<p>Les \u00e9tudes men\u00e9es ces derni\u00e8res ann\u00e9es confirment que la Lp(a) joue un r\u00f4le important dans plusieurs situations :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>progression de l\u2019ath\u00e9roscl\u00e9rose ;<\/li>\n\n\n\n<li>risque augment\u00e9 d\u2019infarctus et d\u2019AVC ;<\/li>\n\n\n\n<li>acc\u00e9l\u00e9ration des calcifications au niveau de la valve aortique ;<\/li>\n\n\n\n<li>aggravation du risque cardiovasculaire chez les personnes atteintes de diab\u00e8te.<\/li>\n<\/ul>\n\n\n\n<p>Ce qui interpelle particuli\u00e8rement les cardiologues, c\u2019est que la Lp(a) reste \u00e9lev\u00e9e m\u00eame chez des patients dont le LDL-cholest\u00e9rol est parfaitement contr\u00f4l\u00e9. Cela explique pourquoi certains continuent \u00e0 faire des \u00e9v\u00e9nements cardiovasculaires malgr\u00e9 des traitements optimaux.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Faut-il doser la Lp(a) ? Les recommandations r\u00e9centes<\/strong><\/h2>\n\n\n\n<p>Les soci\u00e9t\u00e9s savantes recommandent aujourd\u2019hui de mesurer la Lp(a) au moins une fois dans la vie dans plusieurs situations :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>ant\u00e9c\u00e9dents familiaux de maladies cardiaques ou d\u2019accidents vasculaires ;<\/li>\n\n\n\n<li>diab\u00e8te de type 1 ou 2 ;<\/li>\n\n\n\n<li>insuffisance r\u00e9nale ;<\/li>\n\n\n\n<li>suspicion d\u2019ath\u00e9rog\u00e9nicit\u00e9 \u00e9lev\u00e9e.<\/li>\n<\/ul>\n\n\n\n<p>Deux seuils attirent particuli\u00e8rement l\u2019attention :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\u00e0 partir de <strong>125 nmol\/L<\/strong> (environ <strong>0,5 g\/L<\/strong>), le risque commence \u00e0 augmenter ;<\/li>\n\n\n\n<li>au-dessus de <strong>250 nmol\/L<\/strong> (environ <strong>1 g\/L<\/strong>), le risque devient nettement plus \u00e9lev\u00e9.<\/li>\n<\/ul>\n\n\n\n<p>Le test reste simple et rapide, m\u00eame s\u2019il n\u2019est pas rembours\u00e9 partout.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Quelles solutions aujourd\u2019hui ? Et quelles perspectives ?<\/strong><\/h2>\n\n\n\n<p>Les traitements classiques n\u2019ont pratiquement aucun effet sur la Lp(a). Les statines, pourtant essentielles dans la pr\u00e9vention cardiovasculaire, ne la diminuent pas.<\/p>\n\n\n\n<p>Les solutions actuelles sont limit\u00e9es :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>certains inhibiteurs de PCSK9 permettent une baisse d\u2019environ 20 \u00e0 30 % ;<\/li>\n\n\n\n<li>la lipoprot\u00e9ine-aph\u00e9r\u00e8se reste la m\u00e9thode la plus efficace dans les cas s\u00e9v\u00e8res, avec une r\u00e9duction allant jusqu\u2019\u00e0 75 %.<\/li>\n<\/ul>\n\n\n\n<p>La grande nouveaut\u00e9 vient des th\u00e9rapies sp\u00e9cifiques en d\u00e9veloppement. Plusieurs traitements injectables ou oraux, actuellement en phases avanc\u00e9es d\u2019essais cliniques, permettent des r\u00e9ductions tr\u00e8s importantes de la Lp(a). Leur arriv\u00e9e pourrait transformer la strat\u00e9gie de pr\u00e9vention dans les prochaines ann\u00e9es.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Un test simple, un impact potentiel important<\/strong><\/h2>\n\n\n\n<p>Une analyse m\u00e9dico-\u00e9conomique r\u00e9cente montre qu\u2019un d\u00e9pistage syst\u00e9matique de la Lp(a) pourrait \u00e9viter des \u00e9v\u00e9nements cardiovasculaires tout en r\u00e9duisant les co\u00fbts de prise en charge \u00e0 long terme. Pour une cohorte de 10 000 patients d\u00e9pist\u00e9s, plusieurs dizaines d\u2019infarctus pourraient \u00eatre \u00e9vit\u00e9s.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Conclusion<\/strong><\/h2>\n\n\n\n<p>La Lp(a) fait partie de ces marqueurs dont on a sous-estim\u00e9 l\u2019importance pendant trop longtemps. Sa mesure peut r\u00e9v\u00e9ler un risque ignor\u00e9 jusque-l\u00e0, m\u00eame chez des personnes ayant un mode de vie exemplaire ou un cholest\u00e9rol bien contr\u00f4l\u00e9.<\/p>\n\n\n\n<p>Dans un contexte o\u00f9 les nouvelles th\u00e9rapeutiques se rapprochent de leur mise sur le march\u00e9, conna\u00eetre son taux de Lp(a) devient un \u00e9l\u00e9ment essentiel pour mieux anticiper et r\u00e9duire le risque cardiovasculaire.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La lipoprot\u00e9ine(a), souvent not\u00e9e Lp(a), est en train de devenir l\u2019un des marqueurs les plus discut\u00e9s en pr\u00e9vention cardiovasculaire. Ce sujet, trop longtemps laiss\u00e9 de c\u00f4t\u00e9, revient aujourd\u2019hui au premier plan gr\u00e2ce \u00e0 l\u2019accumulation de donn\u00e9es montrant son r\u00f4le direct dans le d\u00e9veloppement des maladies du c\u0153ur et des art\u00e8res. Lp(a), un facteur de risque [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[14],"tags":[],"class_list":["post-453","post","type-post","status-publish","format-standard","hentry","category-14"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Lipoprot\u00e9ine(a) : un marqueur cardiovasculaire longtemps n\u00e9glig\u00e9, aujourd\u2019hui indispensable - Solfed<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/solfed.fr\/?p=453\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lipoprot\u00e9ine(a) : un marqueur cardiovasculaire longtemps n\u00e9glig\u00e9, aujourd\u2019hui indispensable - Solfed\" \/>\n<meta property=\"og:description\" content=\"La lipoprot\u00e9ine(a), souvent not\u00e9e Lp(a), est en train de devenir l\u2019un des marqueurs les plus discut\u00e9s en pr\u00e9vention cardiovasculaire. Ce sujet, trop longtemps laiss\u00e9 de c\u00f4t\u00e9, revient aujourd\u2019hui au premier plan gr\u00e2ce \u00e0 l\u2019accumulation de donn\u00e9es montrant son r\u00f4le direct dans le d\u00e9veloppement des maladies du c\u0153ur et des art\u00e8res. Lp(a), un facteur de risque [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/solfed.fr\/?p=453\" \/>\n<meta property=\"og:site_name\" content=\"Solfed\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-02T12:57:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-02T15:26:35+00:00\" \/>\n<meta name=\"author\" content=\"fouadnassarx\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"fouadnassarx\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/solfed.fr\/?p=453#article\",\"isPartOf\":{\"@id\":\"https:\/\/solfed.fr\/?p=453\"},\"author\":{\"name\":\"fouadnassarx\",\"@id\":\"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/#\/schema\/person\/45018b9be6f3a9994cdd3cc8af14e522\"},\"headline\":\"Lipoprot\u00e9ine(a) : un marqueur cardiovasculaire longtemps n\u00e9glig\u00e9, aujourd\u2019hui indispensable\",\"datePublished\":\"2025-12-02T12:57:31+00:00\",\"dateModified\":\"2025-12-02T15:26:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/solfed.fr\/?p=453\"},\"wordCount\":671,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/#organization\"},\"articleSection\":[\"2025\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/solfed.fr\/?p=453#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/solfed.fr\/?p=453\",\"url\":\"https:\/\/solfed.fr\/?p=453\",\"name\":\"Lipoprot\u00e9ine(a) : un marqueur cardiovasculaire longtemps n\u00e9glig\u00e9, aujourd\u2019hui indispensable - Solfed\",\"isPartOf\":{\"@id\":\"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/#website\"},\"datePublished\":\"2025-12-02T12:57:31+00:00\",\"dateModified\":\"2025-12-02T15:26:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/solfed.fr\/?p=453#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/solfed.fr\/?p=453\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/solfed.fr\/?p=453#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/solfed.fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lipoprot\u00e9ine(a) : un marqueur cardiovasculaire longtemps n\u00e9glig\u00e9, aujourd\u2019hui indispensable\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/#website\",\"url\":\"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/\",\"name\":\"Solfed\",\"description\":\"Renforce les liens scientifiques, organise des congr\u00e8s annuels et partage des ressources de r\u00e9f\u00e9rence en endocrinologie et diab\u00e9tologie.\",\"publisher\":{\"@id\":\"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/#organization\",\"name\":\"Solfed\",\"url\":\"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/solfed.fr\/wp-content\/uploads\/2025\/09\/logo.png\",\"contentUrl\":\"https:\/\/solfed.fr\/wp-content\/uploads\/2025\/09\/logo.png\",\"width\":660,\"height\":204,\"caption\":\"Solfed\"},\"image\":{\"@id\":\"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/#\/schema\/person\/45018b9be6f3a9994cdd3cc8af14e522\",\"name\":\"fouadnassarx\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/4fa4781b79e3e17b649b4d8cbaff803e4bfa39a9694e50f8454641b09df11a79?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/4fa4781b79e3e17b649b4d8cbaff803e4bfa39a9694e50f8454641b09df11a79?s=96&d=mm&r=g\",\"caption\":\"fouadnassarx\"},\"sameAs\":[\"https:\/\/solfed.fr\"],\"url\":\"https:\/\/solfed.fr\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lipoprot\u00e9ine(a) : un marqueur cardiovasculaire longtemps n\u00e9glig\u00e9, aujourd\u2019hui indispensable - Solfed","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/solfed.fr\/?p=453","og_locale":"en_US","og_type":"article","og_title":"Lipoprot\u00e9ine(a) : un marqueur cardiovasculaire longtemps n\u00e9glig\u00e9, aujourd\u2019hui indispensable - Solfed","og_description":"La lipoprot\u00e9ine(a), souvent not\u00e9e Lp(a), est en train de devenir l\u2019un des marqueurs les plus discut\u00e9s en pr\u00e9vention cardiovasculaire. Ce sujet, trop longtemps laiss\u00e9 de c\u00f4t\u00e9, revient aujourd\u2019hui au premier plan gr\u00e2ce \u00e0 l\u2019accumulation de donn\u00e9es montrant son r\u00f4le direct dans le d\u00e9veloppement des maladies du c\u0153ur et des art\u00e8res. Lp(a), un facteur de risque [&hellip;]","og_url":"https:\/\/solfed.fr\/?p=453","og_site_name":"Solfed","article_published_time":"2025-12-02T12:57:31+00:00","article_modified_time":"2025-12-02T15:26:35+00:00","author":"fouadnassarx","twitter_card":"summary_large_image","twitter_misc":{"Written by":"fouadnassarx","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/solfed.fr\/?p=453#article","isPartOf":{"@id":"https:\/\/solfed.fr\/?p=453"},"author":{"name":"fouadnassarx","@id":"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/#\/schema\/person\/45018b9be6f3a9994cdd3cc8af14e522"},"headline":"Lipoprot\u00e9ine(a) : un marqueur cardiovasculaire longtemps n\u00e9glig\u00e9, aujourd\u2019hui indispensable","datePublished":"2025-12-02T12:57:31+00:00","dateModified":"2025-12-02T15:26:35+00:00","mainEntityOfPage":{"@id":"https:\/\/solfed.fr\/?p=453"},"wordCount":671,"commentCount":0,"publisher":{"@id":"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/#organization"},"articleSection":["2025"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/solfed.fr\/?p=453#respond"]}]},{"@type":"WebPage","@id":"https:\/\/solfed.fr\/?p=453","url":"https:\/\/solfed.fr\/?p=453","name":"Lipoprot\u00e9ine(a) : un marqueur cardiovasculaire longtemps n\u00e9glig\u00e9, aujourd\u2019hui indispensable - Solfed","isPartOf":{"@id":"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/#website"},"datePublished":"2025-12-02T12:57:31+00:00","dateModified":"2025-12-02T15:26:35+00:00","breadcrumb":{"@id":"https:\/\/solfed.fr\/?p=453#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/solfed.fr\/?p=453"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/solfed.fr\/?p=453#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/solfed.fr\/"},{"@type":"ListItem","position":2,"name":"Lipoprot\u00e9ine(a) : un marqueur cardiovasculaire longtemps n\u00e9glig\u00e9, aujourd\u2019hui indispensable"}]},{"@type":"WebSite","@id":"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/#website","url":"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/","name":"Solfed","description":"Renforce les liens scientifiques, organise des congr\u00e8s annuels et partage des ressources de r\u00e9f\u00e9rence en endocrinologie et diab\u00e9tologie.","publisher":{"@id":"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/#organization","name":"Solfed","url":"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/solfed.fr\/wp-content\/uploads\/2025\/09\/logo.png","contentUrl":"https:\/\/solfed.fr\/wp-content\/uploads\/2025\/09\/logo.png","width":660,"height":204,"caption":"Solfed"},"image":{"@id":"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/#\/schema\/person\/45018b9be6f3a9994cdd3cc8af14e522","name":"fouadnassarx","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/solfed-bc8f75.ingress-daribow.ewp.live\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/4fa4781b79e3e17b649b4d8cbaff803e4bfa39a9694e50f8454641b09df11a79?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4fa4781b79e3e17b649b4d8cbaff803e4bfa39a9694e50f8454641b09df11a79?s=96&d=mm&r=g","caption":"fouadnassarx"},"sameAs":["https:\/\/solfed.fr"],"url":"https:\/\/solfed.fr\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/solfed.fr\/index.php?rest_route=\/wp\/v2\/posts\/453","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/solfed.fr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/solfed.fr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/solfed.fr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/solfed.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=453"}],"version-history":[{"count":1,"href":"https:\/\/solfed.fr\/index.php?rest_route=\/wp\/v2\/posts\/453\/revisions"}],"predecessor-version":[{"id":456,"href":"https:\/\/solfed.fr\/index.php?rest_route=\/wp\/v2\/posts\/453\/revisions\/456"}],"wp:attachment":[{"href":"https:\/\/solfed.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=453"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/solfed.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=453"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/solfed.fr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=453"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}